BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 16214136)

  • 1. The dimeric form of flavocytochrome P450 BM3 is catalytically functional as a fatty acid hydroxylase.
    Neeli R; Girvan HM; Lawrence A; Warren MJ; Leys D; Scrutton NS; Munro AW
    FEBS Lett; 2005 Oct; 579(25):5582-8. PubMed ID: 16214136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O; Scrutton NS; Munro AW
    Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
    Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
    Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obligatory intermolecular electron-transfer from FAD to FMN in dimeric P450BM-3.
    Kitazume T; Haines DC; Estabrook RW; Chen B; Peterson JA
    Biochemistry; 2007 Oct; 46(42):11892-901. PubMed ID: 17902705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of key active-site residues in flavocytochrome P450 BM3.
    Noble MA; Miles CS; Chapman SK; Lysek DA; MacKay AC; Reid GA; Hanzlik RP; Munro AW
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):371-9. PubMed ID: 10191269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen activation and electron transfer in flavocytochrome P450 BM3.
    Ost TW; Clark J; Mowat CG; Miles CS; Walkinshaw MD; Reid GA; Chapman SK; Daff S
    J Am Chem Soc; 2003 Dec; 125(49):15010-20. PubMed ID: 14653735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3.
    Noble MA; Quaroni L; Chumanov GD; Turner KL; Chapman SK; Hanzlik RP; Munro AW
    Biochemistry; 1998 Nov; 37(45):15799-807. PubMed ID: 9843385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox control of the catalytic cycle of flavocytochrome P-450 BM3.
    Daff SN; Chapman SK; Turner KL; Holt RA; Govindaraj S; Poulos TL; Munro AW
    Biochemistry; 1997 Nov; 36(45):13816-23. PubMed ID: 9374858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interactions in cytochrome P450BM3. Fatty acid substrate binding alters electron-transfer properties of the flavoprotein domain.
    Murataliev MB; Feyereisen R
    Biochemistry; 1996 Nov; 35(47):15029-37. PubMed ID: 8942669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavocytochrome P450 BM3 mutant W1046A is a NADH-dependent fatty acid hydroxylase: implications for the mechanism of electron transfer in the P450 BM3 dimer.
    Girvan HM; Dunford AJ; Neeli R; Ekanem IS; Waltham TN; Joyce MG; Leys D; Curtis RA; Williams P; Fisher K; Voice MW; Munro AW
    Arch Biochem Biophys; 2011 Mar; 507(1):75-85. PubMed ID: 20868649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory evolution of P450 BM3 for mediated electron transfer yielding an activity-improved and reductase-independent variant.
    Nazor J; Dannenmann S; Adjei RO; Fordjour YB; Ghampson IT; Blanusa M; Roccatano D; Schwaneberg U
    Protein Eng Des Sel; 2008 Jan; 21(1):29-35. PubMed ID: 18093991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P450 BM3: the very model of a modern flavocytochrome.
    Munro AW; Leys DG; McLean KJ; Marshall KR; Ost TW; Daff S; Miles CS; Chapman SK; Lysek DA; Moser CC; Page CC; Dutton PL
    Trends Biochem Sci; 2002 May; 27(5):250-7. PubMed ID: 12076537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain.
    Murataliev MB; Klein M; Fulco A; Feyereisen R
    Biochemistry; 1997 Jul; 36(27):8401-12. PubMed ID: 9204888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are branched chain fatty acids the natural substrates for P450(BM3)?
    Cryle MJ; Espinoza RD; Smith SJ; Matovic NJ; De Voss JJ
    Chem Commun (Camb); 2006 Jun; (22):2353-5. PubMed ID: 16733577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
    Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
    Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cobaltocene-mediated catalytic monooxygenation using holo and heme domain cytochrome P450 BM3.
    Udit AK; Arnold FH; Gray HB
    J Inorg Biochem; 2004 Sep; 98(9):1547-50. PubMed ID: 15337607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytically functional flavocytochrome chimeras of P450 BM3 and nitric oxide synthase.
    Fuziwara S; Sagami I; Rozhkova E; Craig D; Noble MA; Munro AW; Chapman SK; Shimizu T
    J Inorg Biochem; 2002 Sep; 91(4):515-26. PubMed ID: 12237219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of dioxygen catalyzed by pyrene-wired heme domain cytochrome P450 BM3 electrodes.
    Udit AK; Hill MG; Bittner VG; Arnold FH; Gray HB
    J Am Chem Soc; 2004 Aug; 126(33):10218-9. PubMed ID: 15315414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the interactions of cytochrome b5 with flavocytochrome P450 BM3 and its domains.
    Noble MA; Girvan HM; Smith SJ; Smith WE; Murataliev M; Guzov VM; Feyereisen R; Munro AW
    Drug Metab Rev; 2007; 39(2-3):599-617. PubMed ID: 17786641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unusual redox properties of flavocytochrome P450 BM3 flavodoxin domain.
    Hanley SC; Ost TW; Daff S
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1418-23. PubMed ID: 15555585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.